Category: Outcomes Assessment

IS NEWLY INVENTED THROMBIN-RECEPTOR ANTAGONIST (TRA) EFFECTIVE AND SAFE ENOUGH TO COMBAT WITH HEART DISEASE?

Callaghan, NSW, Australia – Acute Coronary Syndrome (ACS) and Coronary Heart Disease (CHD) are important contributors to the increased morbidity and mortality rates worldwide. Currently, pharmacotherapy is the main treatment modality for patients with a history of ACS or CHD.

Posted in ISPOR News & Press, Outcomes Assessment, Value in Health Regional Issues Tagged with: , ,

Payers And Regulators Raise The Bar In Europe

Solna, Sweden – European economies are slowly recovering from economic crises and a number of austerity measures undertaken throughout the last five years. At the same time, payers and regulators within the health care sector are increasing their requirements in order

Posted in ISPOR CONNECTIONS, Outcomes Assessment, Value & Outcomes Spotlight Tagged with: , , ,